ClariMed, Inc.
Kelley Kendle is an accomplished executive with extensive experience in the life sciences and healthcare sectors. Currently serving as CEO and Chair at ClariMed, Inc. since August 2022, Kelley also holds positions as Operating Partner at NaviMed Capital, Board Member at Canopy Life Sciences, and Board Member at JPA Health. An expert in strategic advisory services, Kelley has been the Principal Advisor at KHK Advisory since May 2019. Previously, Kelley had a lengthy tenure at Certara, where roles included Chief Solutions Officer and President of the Global Division Head for Regulatory Strategy, Science and Services. Educational background includes a BS in Finance and Operations Management from the Alfred Lerner College of Business & Economics at the University of Delaware.
This person is not in any teams
ClariMed, Inc.
At ClariMed we are clarifying the pathway for usable medical products. We are a human-centered medical device development and regulatory services company accelerating time to market, improving safety, and enabling innovation for pharma and medtech teams while enhancing outcomes and enriching the quality of life for their users. Through embedding human factors and other user focused and risk-mitigated services we partner with our clients to develop innovative medical technologies and make them accessible to the communities who need them. Industries served: Pharma, Biotech, Medtech/device Services offered: UI/UX Human Factors Research & Validation ID & Engineering Digital Health Services Cybersecurity Regulatory